Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells

Biochemical and Biophysical Research Communications

Volumn 299, Issue 5, 2002, Pages 886-890

  Li, Guoping ^a   Yang, Tian ^a   Yan, Jun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; COX 2; Indomethacin; Invasiveness; MMP 2; NS 398; uPA; VEGF

Indexed keywords

CYCLOOXYGENASE 2; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER INVASION; CELL LINE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; TUMOR CELL;

CARCINOMA, TRANSITIONAL CELL; CELL LINE; CELL MOVEMENT; COCULTURE TECHNIQUES; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; LYMPHOKINES; MATRIX METALLOPROTEINASE 2; MEMBRANE PROTEINS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR; UROLOGIC NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

VECTORS;

EID: 0036926092     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02707-9     Document Type: Article

References (20)

1. A.K. Kubba, Non-steroidal anti-inflammatory drugs and colorectal cancer: Is there a way forward?, Eur. J. Cancer 35 (1999) 892-901.
2. G. Gridley, J.K. McLaughlin, A. Ekbom, et al., Incidence of cancer among patients with rheumatoid arthritis, J. Natl. Cancer Inst. 85 (1993) 307-311.
3. M.J. Thun, M.M. Namboodiri, E.E. Calle, et al., Aspirin use and risk of fatal cancer, Cancer Res. 52 (1993) 1322-1327.
4. C.S. Williams, M. Mann, R.N. DuBois, The role of cyclooxygenases in inflammation, cancer, and development, Oncogene 18 (1999) 7908-7916.
5. C.J. Barnes, I.L. Cameron, W.E. Hardman, et al., Non-steroidal anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis, Br. J. Cancer 77 (1998) 573-580.
6. F.M. Giardiello, G.J. Offerhans, R.N. DuBois, The role of non-steroidal anti-inflammatory drugs in colorectal cancer prevention, Eur. J. Cancer 31 (1995) 1071-1076.
7. H. Sawaoka, S. Kawano, S. Tsuji, et al., Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice, Am. J. Physiol. 274 (1998) G1061-1067.
8. O. Ryo, Y. Keigo, F. Takeshi, et al., Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma, Cancer 91 (2001) 1876-1881.
9. K. Namita, Y. Qingyuan, D. Russell, et al., Increased cyclooxygenase-2 (COX-2) expression and activity in a murine model of metastatic breast cancer, Int. J. Cancer 93 (2001) 681-686.
10. K. Kozaki, K. Koshikawa, Y. Tatematsu, et al., Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis, Oncogene 20 (2001) 4228-4234.
11. M. Tsujii, S. Kawano, S. Tsuji, et al., Cyclooxygenase regulates angiogenesis induced by colon cancer cells, Cell 93 (1998) 705-716.
12. H. Sawaoka, S. Tsuji, M. Tsujii, et al., Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo, Lab. Invest. 79 (1999) 1469-1477.
13. J. Folkman, Y. Shing, Angiogenesis, J. Biol. Chem. 267 (1992) 10931-10934.
14. P.A.A. Andreasen, R. Egelund, H.H. Petersen, The plasminogen activation system in tumor growth, invasion, and metastasis, Cell. Mol. Life Sci. 57 (2000) 25-40.
15. L.A. Liotta, K. Tryggvason, S. Garbisa, et al., Metastatic potential correlates with enzymatic degradation of basement membrane collagen, Nature 84 (1980) 67-68.
16. K. Takahiro, T. Yoshitaka, S. Toshiki, et al., Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygnease 1 and 2 in human colon carcinoma cells, Biochim. Biophys. Acta 1438 (1999) 120-130.
17. A. Albini, Y. Iwarnato, H.K. Kleinman, et al., A rapid in vitro assay for quantitating the invasive potential of tumor cells, Cancer Res. 47 (1987) 3239-3245.
18. B.S. Reddy, C.U. Rao, K. Seibert, Evaluation of cyclooxygenase-2 inhibitors for potential chemopreventive properties in colon carcinogenesis, Cancer Res. 56 (1996) 4566-4569.
19. J.S. Kurt, A.K. Arieh, H. Bruce, et al., Cyclooxygenase-1 is up-regulated in cervical carcinomas: Autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin E receptors, and angiogenic factors by cyclooxygenase-1, Cancer Res. 62 (2002) 424-432.
20. K. Namita, M.F. Amy, Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer, Cancer Res. 62 (2002) 2343-2346.